{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:50:21Z","timestamp":1790769021636,"version":"4.1.0"},"reference-count":109,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R21NS070072"],"award-info":[{"award-number":["1R21NS070072"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"DOI":"10.3389\/fnins.2017.00544","type":"journal-article","created":{"date-parts":[[2017,10,10]],"date-time":"2017-10-10T04:17:18Z","timestamp":1507609038000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Optimization of trans-Splicing for Huntington's Disease RNA Therapy"],"prefix":"10.3389","volume":"11","author":[{"given":"Hansj\u00f6rg","family":"Rindt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colton M.","family":"Tom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian L.","family":"Lorson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia B.","family":"Mattis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,10,10]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group","volume":"72","year":"1993","journal-title":"Cell"},{"key":"B2","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.stem.2012.04.026","article-title":"Genetic correction of Huntington's disease phenotypes in induced pluripotent stem cells","volume":"11","author":"An","year":"2012","journal-title":"Cell Stem Cell."},{"key":"B3","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/ng0893-398","article-title":"The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease","volume":"4","author":"Andrew","year":"1993","journal-title":"Nat Genet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1001\/archneur.65.4.482","article-title":"Rapid eye movement sleep disturbances in Huntington disease","volume":"65","author":"Arnulf","year":"2008","journal-title":"Arch. Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/nature02998","article-title":"Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death","volume":"431","author":"Arrasate","year":"2004","journal-title":"Nature"},{"key":"B6","doi-asserted-by":"publisher","first-page":"RRN1235","DOI":"10.1371\/currents.RRN1235","article-title":"Association between age and striatal volume stratified by CAG repeat length in prodromal huntington disease","volume":"3","author":"Aylward","year":"2011","journal-title":"PLoS Curr"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e1002481","DOI":"10.1371\/journal.pgen.1002481","article-title":"A pathogenic mechanism in Huntington's disease involves small CAG-repeated RNAs with neurotoxic activity","volume":"8","author":"Ba\u00f1ez Coronel","year":"2012","journal-title":"PLoS Genet"},{"key":"B8","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.neuron.2015.10.038","article-title":"RAN translation in huntington disease","volume":"88","author":"Ba\u00f1ez Coronel","year":"2015","journal-title":"Neuron"},{"key":"B9","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/wrna.1347","article-title":"mRNA trans-splicing in gene therapy for genetic diseases","volume":"7","author":"Berger","year":"2016","journal-title":"Wiley Interdiscip. Rev"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/nbt1095-1110","article-title":"Redox state of single chain Fv fragments targeted to the endoplasmic reticulum, cytosol and mitochondria","volume":"13","author":"Biocca","year":"1995","journal-title":"Biotechnology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1097\/00001756-199707070-00031","article-title":"Fast transport and retrograde movement of huntingtin and HAP 1 in axons","volume":"8","author":"Block-Galarza","year":"1997","journal-title":"Neuroreport"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/mt.2009.17","article-title":"Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington's disease mice","volume":"17","author":"Boudreau","year":"2009","journal-title":"Mol. Ther."},{"key":"B13","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1101\/lm.500907","article-title":"Histone modifications around individual BDNF gene promoters in prefrontal cortex are associated with extinction of conditioned fear","volume":"14","author":"Bredy","year":"2007","journal-title":"Learn. Mem."},{"key":"B14","doi-asserted-by":"publisher","first-page":"12185","DOI":"10.1073\/pnas.95.21.12185","article-title":"Natural trans-splicing in carnitine octanoyltransferase pre-mRNAs in rat liver","volume":"95","author":"Caudevilla","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1038\/nm900","article-title":"Phenotype correction of hemophilia A mice by spliceosome-mediated RNA trans-splicing","volume":"9","author":"Chao","year":"2003","journal-title":"Nat. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/gt.2008.150","article-title":"Correction of dystrophia myotonica type 1 pre-mRNA transcripts by artificial trans-splicing","volume":"16","author":"Chen","year":"2009","journal-title":"Gene Ther."},{"key":"B17","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1523\/JNEUROSCI.4489-09.2010","article-title":"Trans-splicing-mediated improvement in a severe mouse model of spinal muscular atrophy","volume":"30","author":"Coady","year":"2010","journal-title":"J. Neurosci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1038\/sj.mt.6300222","article-title":"Restoration of SMN function: delivery of a trans-splicing RNA re-directs SMN2 pre-mRNA splicing","volume":"15","author":"Coady","year":"2007","journal-title":"Mol. Ther."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e3468","DOI":"10.1371\/journal.pone.0003468","article-title":"Development of a single vector system that enhances trans-splicing of SMN2 transcripts","volume":"3","author":"Coady","year":"2008","journal-title":"PLoS ONE"},{"key":"B20","doi-asserted-by":"publisher","first-page":"17616","DOI":"10.1073\/pnas.0408134101","article-title":"Potent inhibition of huntingtin aggregation and cytotoxicity by a disulfide bond-free single-domain intracellular antibody","volume":"101","author":"Colby","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.SA."},{"key":"B21","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nbt.3440","article-title":"Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain","volume":"34","author":"Deverman","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/0896-6273(95)90346-1","article-title":"Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons","volume":"14","author":"DiFiglia","year":"1995","journal-title":"Neuron"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"key":"B24","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/81593","article-title":"Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice","volume":"26","author":"Dragatsis","year":"2000","journal-title":"Nat. Genet."},{"key":"B25","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/ana.21569","article-title":"Sustained effects of nonallele-specific Huntingtin silencing","volume":"65","author":"Drouet","year":"2009","journal-title":"Ann. Neurol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/ng0893-387","article-title":"Trinucleotide repeat length instability and age of onset in Huntington's disease","volume":"4","author":"Duyao","year":"1993","journal-title":"Nat. Genet."},{"key":"B27","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1126\/science.7618107","article-title":"Inactivation of the mouse Huntington's disease gene homolog Hdh","volume":"269","author":"Duyao","year":"1995","journal-title":"Science"},{"key":"B28","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.scr.2013.01.009","article-title":"EZ spheres: a stable and expandable culture system for the generation of pre-rosette multipotent stem cells from human ESCs and iPSCs","volume":"10","author":"Ebert","year":"2013","journal-title":"Stem Cell Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nature03481","article-title":"The genome of the social amoeba Dictyostelium discoideum","volume":"435","author":"Eichinger","year":"2005","journal-title":"Nature"},{"key":"B30","doi-asserted-by":"publisher","first-page":"26244","DOI":"10.1074\/jbc.M203513200","article-title":"Natural trans-spliced mRNAs are generated from the human estrogen receptor-alpha (hER alpha) gene","volume":"277","author":"Flouriot","year":"2002","journal-title":"J. Biol. Chem."},{"key":"B31","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1172\/JCI200319462","article-title":"Messenger RNA reprogramming by spliceosome-mediated RNA trans-splicing","volume":"112","author":"Garcia-Blanco","year":"2003","journal-title":"J. Clin. Invest."},{"key":"B32","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/ncb735","article-title":"Recruitment and activation of caspase-8 by the Huntingtin-interacting protein Hip-1 and a novel partner Hippi","volume":"4","author":"Gervais","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.cell.2006.04.026","article-title":"Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin","volume":"125","author":"Graham","year":"2006","journal-title":"Cell"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1089\/hum.2010.245","article-title":"Optimizing promoters for recombinant adeno-associated virus-mediated gene expression in the peripheral and central nervous system using self-complementary vectors","volume":"22","author":"Gray","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"B35","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S1525-0016(02)00047-3","article-title":"Stable genetic modification of human embryonic stem cells by lentiviral vectors","volume":"7","author":"Gropp","year":"2003","journal-title":"Mol. Ther."},{"key":"B36","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.neuron.2009.11.020","article-title":"Serines 13 and 16 are critical determinants of full-length human mutant huntingtin induced disease pathogenesis in HD mice","volume":"64","author":"Gu","year":"2009","journal-title":"Neuron"},{"key":"B37","doi-asserted-by":"publisher","first-page":"8710","DOI":"10.1073\/pnas.92.19.8710","article-title":"Identification and localization of huntingtin in brain and human lymphoblastoid cell lines with anti-fusion protein antibodies","volume":"92","author":"Gutekunst","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B38","doi-asserted-by":"publisher","first-page":"6739","DOI":"10.1073\/pnas.110138997","article-title":"Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: implications for Huntington's disease therapy","volume":"97","author":"Heiser","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B39","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/embor.2010.182","article-title":"Is Huntington disease a developmental disorder?","volume":"11","author":"Humbert","year":"2010","journal-title":"EMBO Rep."},{"key":"B40","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/ng864","article-title":"A bivalent Huntingtin binding peptide suppresses polyglutamine aggregation and pathogenesis in Drosophila","volume":"30","author":"Kazantsev","year":"2002","journal-title":"Nat. Genet."},{"key":"B41","doi-asserted-by":"publisher","first-page":"7466","DOI":"10.1074\/jbc.M103946200","article-title":"Huntingtin is present in the nucleus, interacts with the transcriptional corepressor C-terminal binding protein, and represses transcription","volume":"277","author":"Kegel","year":"2002","journal-title":"J. Biol. Chem."},{"key":"B42","doi-asserted-by":"publisher","first-page":"R53","DOI":"10.1093\/hmg\/ddv442","article-title":"Gene suppression strategies for dominantly inherited neurodegenerative diseases: lessons from Huntington's disease and spinocerebellar ataxia","volume":"25","author":"Keiser","year":"2016","journal-title":"Hum. Mol. Genet"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1073\/pnas.022631799","article-title":"Effects of intracellular expression of anti-huntingtin antibodies of various specificities on mutant huntingtin aggregation and toxicity","volume":"99","author":"Khoshnan","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B44","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3390\/ijms18040754","article-title":"CRISPR-Cas9 mediated gene-silencing of the mutant huntingtin gene in an in vitro model of huntington's disease","volume":"18","author":"Kolli","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.neuron.2012.05.009","article-title":"Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesis","volume":"74","author":"Kordasiewicz","year":"2012","journal-title":"Neuron"},{"key":"B46","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1002\/1531-8249(199912)46:6<842::AID-ANA6>3.0.CO;2-O","article-title":"Huntington aggregates may not predict neuronal death in Huntington's disease","volume":"46","author":"Kuemmerle","year":"1999","journal-title":"Ann. Neurol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"4764","DOI":"10.1073\/pnas.071058398","article-title":"Human single-chain Fv intrabodies counteract in situ huntingtin aggregation in cellular models of Huntington's disease","volume":"98","author":"Lecerf","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1038\/ncomms3753","article-title":"Soluble forms of polyQ-expanded huntingtin rather than large aggregates cause endoplasmic reticulum stress","volume":"4","author":"Leitman","year":"2013","journal-title":"Nat. Commun."},{"key":"B49","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nbt0102-47","article-title":"Partial correction of endogenous DeltaF508 CFTR in human cystic fibrosis airway epithelia by spliceosome-mediated RNA trans-splicing","volume":"20","author":"Liu","year":"2002","journal-title":"Nat. Biotechnol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/sj.mt.6300377","article-title":"Transient immunomodulation allows repeated injections of AAV1 and correction of muscular dystrophy in multiple muscles","volume":"16","author":"Lorain","year":"2008","journal-title":"Mol. Ther."},{"key":"B51","doi-asserted-by":"publisher","first-page":"8391","DOI":"10.1093\/nar\/gkt621","article-title":"Dystrophin rescue by trans-splicing: a strategy for DMD genotypes not eligible for exon skipping approaches","volume":"41","author":"Lorain","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.neuron.2012.06.001","article-title":"Huntingtin holiday: progress toward an antisense therapy for Huntington's disease","volume":"74","author":"Lu","year":"2012","journal-title":"Neuron"},{"key":"B53","doi-asserted-by":"publisher","first-page":"268r","DOI":"10.1126\/scitranslmed.3010523","article-title":"Targeting ATM ameliorates mutant Huntingtin toxicity in cell and animal models of Huntington's disease","volume":"6","author":"Lu","year":"2014","journal-title":"Sci. Transl. Med"},{"key":"B54","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S1097-2765(02)00602-0","article-title":"Proteases acting on mutant huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions","volume":"10","author":"Lunkes","year":"2002","journal-title":"Mol. Cell"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1038\/sj.gt.3301307","article-title":"Repair of CFTR mRNA by spliceosome-mediated RNA trans-splicing","volume":"7","author":"Mansfield","year":"2000","journal-title":"Gene Ther."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1261\/rna.5101903","article-title":"5 exon replacement and repair by spliceosome-mediated RNA trans-splicing","volume":"9","author":"Mansfield","year":"2003","journal-title":"Rna"},{"key":"B57","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1093\/hmg\/ddv080","article-title":"HD iPSC-derived neural progenitors accumulate in culture and are susceptible to BDNF withdrawal due to glutamate toxicity","volume":"24","author":"Mattis","year":"2015","journal-title":"Hum. Mol. Genet"},{"key":"B58","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1038\/mt.2011.219","article-title":"Preclinical safety of RNAi-mediated HTT suppression in the rhesus macaque as a potential therapy for Huntington's disease","volume":"19","author":"McBride","year":"2011","journal-title":"Mol. Ther."},{"key":"B59","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.scr.2016.02.027","article-title":"Targeted genome engineering using designer nucleases: state of the art and practical guidance for application in human pluripotent stem cells","volume":"16","author":"Merkert","year":"2016","journal-title":"Stem Cell Res."},{"key":"B60","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/nchembio.694","article-title":"Identifying polyglutamine protein species in situ that best predict neurodegeneration","volume":"7","author":"Miller","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1172\/JCI45691","article-title":"Energy deficit in Huntington disease: why it matters","volume":"121","author":"Mochel","year":"2011","journal-title":"J. Clin. Invest."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/mt.2014.35","article-title":"Cis-splicing and translation of the pre-trans-splicing molecule combine with efficiency in spliceosome-mediated RNA trans-splicing","volume":"22","author":"Monjaret","year":"2014","journal-title":"Mol. Ther."},{"key":"B63","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/jid.2010.249","article-title":"Functional correction of type VII collagen expression in dystrophic epidermolysis bullosa","volume":"131","author":"Murauer","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/0092-8674(86)90616-1","article-title":"Identification of a novel Y branch structure as an intermediate in trypanosome mRNA processing: evidence for trans splicing","volume":"47","author":"Murphy","year":"1986","journal-title":"Cell"},{"key":"B65","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/0092-8674(95)90542-1","article-title":"Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes","volume":"81","author":"Nasir","year":"1995","journal-title":"Cell"},{"key":"B66","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/S0006-8993(98)01312-2","article-title":"Neuronal degeneration in the basal ganglia and loss of pallido-subthalamic synapses in mice with targeted disruption of the Huntington's disease gene","volume":"818","author":"O'Kusky","year":"1999","journal-title":"Brain Res."},{"key":"B67","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.celrep.2013.06.034","article-title":"SUMO-2 and PIAS1 modulate insoluble mutant huntingtin protein accumulation","volume":"4","author":"O'Rourke","year":"2013","journal-title":"Cell Rep."},{"key":"B68","doi-asserted-by":"publisher","first-page":"9634","DOI":"10.1093\/nar\/gkt725","article-title":"Rational design of antisense oligonucleotides targeting single nucleotide polymorphisms for potent and allele selective suppression of mutant Huntingtin in the CNS","volume":"41","author":"\u00d8stergaard","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1002\/mds.25075","article-title":"The incidence and prevalence of Huntington's disease: a systematic review and meta-analysis","volume":"27","author":"Pringsheim","year":"2012","journal-title":"Mov. Disord."},{"key":"B70","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1523\/JNEUROSCI.4540-10.2011","article-title":"Identification of cis-elements and transcription factors regulating neuronal activity-dependent transcription of human BDNF gene","volume":"31","author":"Pruunsild","year":"2011","journal-title":"J. Neurosci."},{"key":"B71","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/6986","article-title":"Spliceosome-mediated RNA trans-splicing as a tool for gene therapy","volume":"17","author":"Puttaraju","year":"1999","journal-title":"Nat. Biotechnol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.celrep.2017.04.029","article-title":"Huntingtin inclusions trigger cellular quiescence, deactivate apoptosis, and lead to delayed necrosis","volume":"19","author":"Ramdzan","year":"2017","journal-title":"Cell Rep."},{"key":"B73","doi-asserted-by":"publisher","first-page":"10855","DOI":"10.1074\/jbc.M804813200","article-title":"Mutant huntingtin N-terminal fragments of specific size mediate aggregation and toxicity in neuronal cells","volume":"284","author":"Ratovitski","year":"2009","journal-title":"J. Biol. Chem."},{"key":"B74","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1523\/JNEUROSCI.20-10-03705.2000","article-title":"Wild-type huntingtin protects from apoptosis upstream of caspase-3","volume":"20","author":"Rigamonti","year":"2000","journal-title":"J. Neurosci."},{"key":"B75","doi-asserted-by":"publisher","first-page":"14545","DOI":"10.1074\/jbc.C100044200","article-title":"Huntingtin's neuroprotective activity occurs via inhibition of procaspase-9 processing","volume":"276","author":"Rigamonti","year":"2001","journal-title":"J. Biol. Chem."},{"key":"B76","doi-asserted-by":"publisher","first-page":"4191","DOI":"10.1007\/s00018-012-1083-5","article-title":"Replacement of huntingtin exon 1 by trans-splicing","volume":"69","author":"Rindt","year":"2012","journal-title":"Cell Mol. Life Sci."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.stemcr.2015.11.005","article-title":"Genomic analysis reveals disruption of striatal neuronal development and therapeutic targets in human huntington's disease neural stem cells","volume":"5","author":"Ring","year":"2015","journal-title":"Stem Cell Rep."},{"key":"B78","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1055\/s-0043-108061","article-title":"Hope for Huntington's disease patients: first clinical gene silencing study in progress","volume":"85","author":"Rollnik","year":"2017","journal-title":"Fortschr. Neurol. Psychiatr."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1093\/brain\/awn025","article-title":"Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity","volume":"131","author":"Rosas","year":"2008","journal-title":"Brain"},{"key":"B80","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington's disease: from molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S0092-8674(00)80514-0","article-title":"Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo","volume":"90","author":"Scherzinger","year":"1997","journal-title":"Cell"},{"key":"B82","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s12031-011-9614-3","article-title":"Optimization of SMN trans-splicing through the analysis of SMN introns","volume":"46","author":"Shababi","year":"2012","journal-title":"J. Mol. Neurosci."},{"key":"B83","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1089\/hum.2010.114","article-title":"Combination of SMN trans-splicing and a neurotrophic factor increases the life span and body mass in a severe model of spinal muscular atrophy","volume":"22","author":"Shababi","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"B84","doi-asserted-by":"publisher","first-page":"e107434","DOI":"10.1371\/journal.pone.0107434","article-title":"Allele-specific suppression of mutant huntingtin using antisense oligonucleotides: providing a therapeutic option for all huntington disease patients","volume":"9","author":"Skotte","year":"2014","journal-title":"PLoS ONE"},{"key":"B85","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1038\/mt.2014.153","article-title":"In vivo evaluation of candidate allele-specific mutant huntingtin gene silencing antisense oligonucleotides","volume":"22","author":"Southwell","year":"2014","journal-title":"Mol. Ther."},{"key":"B86","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1126\/science.1092194","article-title":"SUMO modification of Huntingtin and Huntington's disease pathology","volume":"304","author":"Steffan","year":"2004","journal-title":"Science"},{"key":"B87","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0168-9525(03)00074-X","article-title":"Transcriptional abnormalities in Huntington disease","volume":"19","author":"Sugars","year":"2003","journal-title":"Trends Genet."},{"key":"B88","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/0092-8674(86)90617-3","article-title":"Evidence for trans splicing in trypanosomes","volume":"47","author":"Sutton","year":"1986","journal-title":"Cell"},{"key":"B89","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0165-0270(98)00126-5","article-title":"A new method for the rapid and long term growth of human neural precursor cells","volume":"85","author":"Svendsen","year":"1998","journal-title":"J. Neurosci. Methods"},{"key":"B90","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/nm1086","article-title":"Trans-splicing repair of CD40 ligand deficiency results in naturally regulated correction of a mouse model of hyper-IgM X-linked immunodeficiency","volume":"10","author":"Tahara","year":"2004","journal-title":"Nat. Med."},{"key":"B91","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1093\/hmg\/ddm311","article-title":"Soluble polyglutamine oligomers formed prior to inclusion body formation are cytotoxic","volume":"17","author":"Takahashi","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"B92","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1471-2202-3-15","article-title":"The predominantly HEAT-like motif structure of huntingtin and its association and coincident nuclear entry with dorsal, an NF-kB\/Rel\/dorsal family transcription factor","volume":"3","author":"Takano","year":"2002","journal-title":"BMC Neurosci."},{"key":"B93","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.2174\/0929867321666140217124038","article-title":"Peptide-based therapeutic approaches for treatment of the polyglutamine diseases","volume":"21","author":"Takeuchi","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"B94","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.stem.2012.04.027","article-title":"Induced pluripotent stem cells from patients with Huntington's disease show CAG-repeat-expansion-associated phenotypes","volume":"11","year":"2012","journal-title":"Cell Stem Cell"},{"key":"B95","doi-asserted-by":"publisher","first-page":"36798","DOI":"10.1038\/srep36798","article-title":"Glycation potentiates neurodegeneration in models of Huntington's disease","volume":"6","author":"Vicente Miranda","year":"2016","journal-title":"Sci. Rep."},{"key":"B96","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington's disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/S0072-9752(07)01256-0","article-title":"Neuropathology of Huntington's disease","volume":"89","author":"Vonsattel","year":"2008","journal-title":"Handb. Clin. Neurol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/sj.jid.5701152","article-title":"5 trans-splicing repair of the PLEC1 gene","volume":"128","author":"Wally","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"4715","DOI":"10.1093\/hmg\/ddq405","article-title":"K14 mRNA reprogramming for dominant epidermolysis bullosa simplex","volume":"19","author":"Wally","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"B100","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1093\/hmg\/ddi395","article-title":"Induction of HSP70 expression and recruitment of HSC70 and HSP70 in the nucleus reduce aggregation of a polyalanine expansion mutant of PABPN1 in HeLa cells","volume":"14","author":"Wang","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"B101","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1073\/pnas.1524575113","article-title":"Ablation of huntingtin in adult neurons is nondeleterious but its depletion in young mice causes acute pancreatitis","volume":"113","author":"Wang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B102","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/70532","article-title":"Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70","volume":"23","author":"Warrick","year":"1999","journal-title":"Nat. Genet."},{"key":"B103","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1101\/gr.159483.113","article-title":"Integrative transcriptome sequencing identifies trans-splicing events with important roles in human embryonic stem cell pluripotency","volume":"24","author":"Wu","year":"2014","journal-title":"Genome Res."},{"key":"B104","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3389\/fnmol.2016.00030","article-title":"CRISPR\/Cas9: implications for modeling and therapy of neurodegenerative diseases","volume":"9","author":"Yang","year":"2016","journal-title":"Front. Mol. Neurosci."},{"key":"B105","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1172\/JCI92087","article-title":"CRISPR\/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington's disease","volume":"127","author":"Yang","year":"2017","journal-title":"J. Clin. Invest."},{"key":"B106","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1006\/nbdi.2002.0502","article-title":"Chemical chaperones reduce aggregate formation and cell death caused by the truncated Machado-Joseph disease gene product with an expanded polyglutamine stretch","volume":"10","author":"Yoshida","year":"2002","journal-title":"Neurobiol. Dis."},{"key":"B107","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1038\/sj.mt.6300178","article-title":"Correction of DNA protein kinase deficiency by spliceosome-mediated RNA trans-splicing and sleeping beauty transposon delivery","volume":"15","author":"Zayed","year":"2007","journal-title":"Mol. Ther."},{"key":"B108","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/ng1095-155","article-title":"Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue","volume":"1","author":"Zeitlin","year":"1995","journal-title":"Nat. Genet."},{"key":"B109","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/scientificamerican0816-56","article-title":"The Huntington's paradox","volume":"315","author":"Zuccato","year":"2016","journal-title":"Sci. Am."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fnins.2017.00544\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T11:31:38Z","timestamp":1570188698000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fnins.2017.00544\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,10]]},"references-count":109,"alternative-id":["10.3389\/fnins.2017.00544"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2017.00544","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,10]]},"article-number":"544"}}